Share pay and Allfunds work explain roughly 57% of Deutsche Börse’s Q3 cost rise

Deutsche Börse’s third-quarter operating costs rose 7% to €646 million. The group said the increase was driven primarily by higher share-based compensation linked to its share-price performance and expenses for the planned Allfunds transaction. On an underlying constant-currency basis, cost growth was about 3%. Reconstructing those two rates against the same prior-year base implies that roughly €24.2 million—about 57% of the reported €42.3 million increase—came from the identified share-pay and transaction-related layer rather than ordinary underlying cost growth.[1]

That figure is approximate because Deutsche Börse publishes rounded growth rates rather than the exact bridge used in the reconstruction. It also cannot be split between employee share compensation and Allfunds work from the public headline. The value is nevertheless analytically useful: more than half of the quarter’s reported cost increase appears to depend on share-price-linked remuneration and a transaction that had not yet completed, rather than the inflation, investment and operating expansion captured in the 3% underlying rate.[1]

The cost bridge changes the interpretation of operating leverage

The bridge does not mean €24.2 million is wholly non-recurring. Share-based compensation can recur and may remain high if awards, employee numbers or the share price stay elevated. Transaction expenses can continue through approval, financing, integration and completion. The distinction is instead between the group’s stated underlying constant-currency growth and the additional cost visible in the reported result. Treating all 7% as ordinary run-rate inflation would overstate the underlying increase; stripping all of the difference forever would understate future expense if the drivers persist.[1]

Deutsche Börse’s revenue and earnings performance remained strong. Net revenue excluding treasury results rose 14% to €1.415 billion, while EBITDA excluding treasury results rose 19% to €760 million. Those rates exceeded both reported and underlying cost growth. The cost reconstruction therefore does not reverse the quarter’s operating-leverage conclusion. It refines the source of expense growth and identifies a meaningful amount tied to compensation and deal execution.[1]

The Allfunds deal is large enough to affect costs before ownership transfers

Deutsche Börse agreed to acquire Allfunds at an equity value of approximately €5.3 billion. The offer combines €6.00 in cash, €2.60 in Deutsche Börse shares and a permitted €0.20 dividend per Allfunds share. Long before legal completion, a transaction of that scale can generate legal, advisory, financing, regulatory, integration-planning and employee costs. Those expenses do not establish that the acquisition is complete or that the expected synergies have been realised.[2]

The company forecasts approximately €60 million of annual run-rate pre-tax cost synergies and €30 million of annual cash capital-expenditure savings. It expects roughly half the cost synergies by the end of 2028. These are management estimates for a future combined group. They should not be netted against current transaction costs as though the benefits had already arrived. Nor should the €90 million of annual targets be compared directly with one quarter’s reconstructed €24.2 million special layer without matching period, definition and cash-versus-accounting treatment.[2]

Shareholder approval is not completion

Allfunds shareholders approved the scheme by more than 99.9% of votes cast according to Deutsche Börse. That removes one condition but does not itself transfer the business. Regulatory approvals, court process and other closing conditions remain relevant. The expected completion window was the first half of 2027. Reporting the transaction as an owned 2026 business would therefore confuse a recommended acquisition with a completed consolidation.[3][2]

This timing matters for the cost denominator. Current Allfunds transaction expenses enter Deutsche Börse’s reported costs before Allfunds revenue and operating profit enter its consolidated perimeter. A pre-close quarter can therefore bear deal costs without the acquired earnings that may later accompany them. That asymmetry is ordinary transaction accounting, not evidence that the target is loss-making or that integration has failed.[1][2][3]

The share-price component links expense to market performance

The other identified driver—share-based compensation—has a different mechanism. Depending on award design and accounting treatment, a rising share price can increase the measured cost of equity-linked or cash-settled employee awards. The company’s successful market performance can therefore raise compensation expense in the same period that investors view the share-price move positively. The cost is economically real, but it is not evidence of equivalent headcount growth or cash salary inflation.[1]

Without the detailed award bridge, an outside reader cannot determine how much of Q3’s increase came from remeasurement, new grants, vesting, headcount or the Allfunds process. Any article assigning a precise euro amount to one of the two drivers would overstate the evidence. The defensible calculation is combined: the gap between 7% reported and 3% underlying growth approximates the layer that management says was driven primarily by both factors.[1]

What the cost bridge says about future quarters

The reconstructed €24.2 million is not automatically a future saving. Some transaction expenses may end at closing; others may be replaced by integration expense. Share compensation may fall if market values or award measurements change, or rise if performance remains strong. The underlying 3% cost base can also accelerate through wage inflation and investment. A forecast should therefore model the drivers separately rather than simply annualising the quarter or removing the whole gap.[1][2]

The next verifiable milestones are completion of the Allfunds conditions, the first consolidated results, a disclosed integration-cost bridge and evidence of realised synergies. Those records can show whether current transaction spending leads to the forecast savings and whether share-based compensation normalises. Until then, the quarter supports a narrower finding: a majority of reported cost growth did not arise from the group’s stated underlying constant-currency increase.[1][2][3]

For exchange-group comparisons, that distinction is essential. One operator may report an apparently higher cost-growth rate because its share price lifted compensation or because it is executing a major transaction; another may exclude similar items from an adjusted measure. Like-for-like analysis requires the same period and classification, not merely two headline percentages. Deutsche Börse’s own disclosure provides enough information to estimate the scale of the difference, but not to pretend that the underlying components are known more precisely than they are.[1]

The evidence therefore supports two simultaneous conclusions. Deutsche Börse delivered strong operating leverage in Q3, with revenue and EBITDA growing faster than costs. It also incurred a reported cost increase of which roughly 57% appears linked to share-based compensation and the Allfunds process rather than underlying constant-currency growth. The first conclusion describes performance; the second explains why the cost line should not be projected mechanically.[1]

A transaction-cost total needs more than the quarterly residual

The €24.2 million reconstruction is not a cumulative Allfunds bill. It includes share-based compensation and covers one quarter. A complete deal-cost total would collect advisory, legal, financing, regulatory, retention, integration and purchase-accounting effects across every reporting period, then separate cash spending from non-cash charges. The current disclosure does not provide that full schedule.[1][2]

Nor can the expected €60 million cost synergy be treated as a guaranteed return on €5.3 billion of equity value. The acquisition case also includes revenue opportunities, strategic positioning, capital expenditure savings, financing cost and execution risk. A simple synergy yield would omit the timing and probability of benefits and the value of Allfunds’ existing earnings.[2]

The share-based-compensation driver also creates a counterintuitive comparison with peers. A company whose share price outperforms may record more expense under certain award structures than a weaker performer, even with similar employee counts. Removing that cost entirely would ignore compensation; comparing it without understanding award design can punish market performance. The underlying/reporting bridge is the appropriate first step, not the final valuation adjustment.[1]

Management’s future quarters can falsify the approximate allocation. If detailed costs show a materially different prior-year base or a constant-currency adjustment not captured by the rounded rates, the €24.2 million estimate should be revised. The calculation is transparent precisely so that it can be replaced by a better company bridge when available.[1]

Report an error or submit an update